Media Pack
News

Current Edition

Volume 7 issue 1

Upcoming Events

 
 

Advertisement

 
news

Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study

Cerevel Therapeutics, a biotechnology company in the midst of being acquired by AbbVie, on Thursday said a Parkinson’s disease treatment it’s developing succeeded in...
22 April 2024 news
Continue Reading →
news

Roche wins FDA OK for Alecensa in early lung cancer

The Food and Drug Administration has made a medicine from Roche the first specifically available for early treatment of lung tumors driven by a well-known cancer gen...
22 April 2024 news
Continue Reading →
news

Vertex begins bid for US approval of non-opioid painkiller

Vertex Pharmaceuticals is vying for approval of an experimental and closely watched painkiller that could become an alternative to addictive opioids like Vicodin. ...
22 April 2024 news
Continue Reading →
news

Alvotech deal could heighten biosimilar pressure on Humira

Dive Brief: Alvotech and U.S. commercial partner Teva have signed a “long-term agreement” with an unspecified company to boost access to their biosimilar version...
22 April 2024 news
Continue Reading →
news

Roche, Adaptimmune part ways on cell therapy research

Dive Brief: Genentech, the research subsidiary of Swiss pharmaceutical giant Roche, has decided to cut short a partnership focused on cell therapies for cancer. ...
15 April 2024 news
Continue Reading →
news

US sues Regeneron, alleging false price reporting on Eylea

The U.S. Department of Justice on Wednesday accused Regeneron of defrauding Medicare by knowingly inflating the average sales price for its top-selling eye drug Eyle...
15 April 2024 news
Continue Reading →
news

European regulator concludes no suicide link to obesity drugs

Dive Brief: Novo Nordisk and Eli Lilly drugs to treat diabetes and obesity have no “causal association” with suicidal thoughts or incidents of suicide or self-ha...
15 April 2024 news
Continue Reading →
news

Private biotech funding rises as venture firms deploy cash

Private funding for biotechnology startups rose during the first three months of the year, suggesting some of the sector’s momentum has translated to stepped-up inve...
15 April 2024 news
Continue Reading →
news

Contineum prices biotech’s latest IPO, raising $110M for neuroinflammatory drugs

Contineum Therapeutics has raised $110 million in an initial public offering, the biotechnology industry’s 10th of the year, to advance a group of drugs it’s develop...
8 April 2024 news
Continue Reading →
news

Boehringer Ingelheim to lay off staff amid biosimilar challenges

Dive Brief: Boehringer Ingelheim is laying off staff in response to sluggish adoption of its Humira biosimilar Cyltezo, a company spokesperson confirmed to BioPh...
8 April 2024 news
Continue Reading →
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte